Skip to main content
OpenTrials

Clinical trial condition

Churg-Strauss Syndrome

Explore clinical trials studying Churg-Strauss Syndrome. Study availability and eligibility vary by location and protocol.

16 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Churg-Strauss Syndrome trial results

Recruiting

Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis

NCT00315380

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +13 more
Locations
  • University of California San Diego San Diego, California, United States
  • National Jewish Health Denver, Colorado, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
View all 13 locations
View Trial Details
Recruiting

VCRC Tissue Repository

NCT02967068

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Aortic Arch Syndromes, Aortic Diseases, +48 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Boston University School of Medicine Boston, Massachusetts, United States
  • Cleveland Clinic Cleveland, Ohio, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Mepolizumab Long-term Study to Assess Real World Safety and Effectiveness of Eosinophilic Granulomatosis With Polyangiitis (EGPA) in Japan

NCT04551989

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +13 more
Locations
  • GSK Investigational Site Aichi, Japan
  • GSK Investigational Site Gunma, Japan
  • GSK Investigational Site Hyōgo, Japan
  • GSK Investigational Site Hyōgo, Japan
View all 34 locations
View Trial Details
Completed

Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921

NCT03298061

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +13 more
Locations
  • GSK Investigational Site Denver, Colorado, United States
  • GSK Investigational Site Bethesda, Maryland, United States
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site Boston, Massachusetts, United States
View all 32 locations
View Trial Details
Completed

A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis

NCT02020889

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +12 more
Locations
  • GSK Investigational Site Denver, Colorado, United States
  • GSK Investigational Site Bethesda, Maryland, United States
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site Boston, Massachusetts, United States
View all 32 locations
View Trial Details

Related conditions